![Targeting the TGF-β signaling pathway for resolution of pulmonary arterial hypertension: Trends in Pharmacological Sciences Targeting the TGF-β signaling pathway for resolution of pulmonary arterial hypertension: Trends in Pharmacological Sciences](https://www.cell.com/cms/attachment/766b8fb4-7810-464a-a96c-8f71d0b12176/gr1_lrg.jpg)
Targeting the TGF-β signaling pathway for resolution of pulmonary arterial hypertension: Trends in Pharmacological Sciences
![Guía de diagnóstico y tratamiento de la hipertensión pulmonar: resumen de recomendaciones | Archivos de Bronconeumología Guía de diagnóstico y tratamiento de la hipertensión pulmonar: resumen de recomendaciones | Archivos de Bronconeumología](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S0300289617304362:gr3.jpeg?xkr=ue/ImdikoIMrsJoerZ+w9zfHQrK7O1GixshFj/RYvvhfIeFLIshOrwnoGDwJytw3sGm8bijV+TbKpnl+SctEd8J6QCKqlZsaAdnZdn5uuNzAEjzCnnvZPJWO/HNQNuuooAEnIugnKAzsmknfe4p5fnC1aRRzlFyH0ie26qjAW9UoBe+iwcdEZXOXb1+6QJz82X2sZe0vPVHOXvDESaPQSyUpauQNzY7t0SDIO1TNy4Q+3V3eKeLh28Wl4SVtp4kele906E7+3BfvSxP4RKn2thtQnKcdtZSAMn9ZiYbQ68g=)
Guía de diagnóstico y tratamiento de la hipertensión pulmonar: resumen de recomendaciones | Archivos de Bronconeumología
![PDF] Pulmonary hypertension and beta blockers: where do we stand? Where are we going? | Semantic Scholar PDF] Pulmonary hypertension and beta blockers: where do we stand? Where are we going? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1051de3c8e6e943e7932b47245d7ee8b5efa2fdc/2-Figure1-1.png)
PDF] Pulmonary hypertension and beta blockers: where do we stand? Where are we going? | Semantic Scholar
![Bioactivities and mechanisms of natural medicines in the management of pulmonary arterial hypertension | Chinese Medicine | Full Text Bioactivities and mechanisms of natural medicines in the management of pulmonary arterial hypertension | Chinese Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13020-022-00568-w/MediaObjects/13020_2022_568_Figa_HTML.png)
Bioactivities and mechanisms of natural medicines in the management of pulmonary arterial hypertension | Chinese Medicine | Full Text
![Frontiers | Therapeutic Approaches for Treating Pulmonary Arterial Hypertension by Correcting Imbalanced TGF-β Superfamily Signaling Frontiers | Therapeutic Approaches for Treating Pulmonary Arterial Hypertension by Correcting Imbalanced TGF-β Superfamily Signaling](https://www.frontiersin.org/files/Articles/814222/fmed-08-814222-HTML/image_m/fmed-08-814222-g001.jpg)
Frontiers | Therapeutic Approaches for Treating Pulmonary Arterial Hypertension by Correcting Imbalanced TGF-β Superfamily Signaling
![Outcomes of β-blocker use in pulmonary arterial hypertension: a propensity-matched analysis | European Respiratory Society Outcomes of β-blocker use in pulmonary arterial hypertension: a propensity-matched analysis | European Respiratory Society](https://erj.ersjournals.com/content/erj/46/3/750/F1.large.jpg)
Outcomes of β-blocker use in pulmonary arterial hypertension: a propensity-matched analysis | European Respiratory Society
![Treatment algorithm for pulmonary hypertension associated with sickle... | Download Scientific Diagram Treatment algorithm for pulmonary hypertension associated with sickle... | Download Scientific Diagram](https://www.researchgate.net/publication/5865066/figure/fig2/AS:601807273349147@1520493443819/Treatment-algorithm-for-pulmonary-hypertension-associated-with-sickle-cell-disease.png)
Treatment algorithm for pulmonary hypertension associated with sickle... | Download Scientific Diagram
![Pharmaceuticals | Free Full-Text | Strategizing Drug Therapies in Pulmonary Hypertension for Improved Outcomes Pharmaceuticals | Free Full-Text | Strategizing Drug Therapies in Pulmonary Hypertension for Improved Outcomes](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-15-01242/article_deploy/html/images/pharmaceuticals-15-01242-g001.png)
Pharmaceuticals | Free Full-Text | Strategizing Drug Therapies in Pulmonary Hypertension for Improved Outcomes
![Treatment Targets for Right Ventricular Dysfunction in Pulmonary Arterial Hypertension | JACC: Basic to Translational Science Treatment Targets for Right Ventricular Dysfunction in Pulmonary Arterial Hypertension | JACC: Basic to Translational Science](https://www.jacc.org/cms/asset/51c5bd47-46ea-4e85-93eb-aae22c80cfcf/gr3.jpg)
Treatment Targets for Right Ventricular Dysfunction in Pulmonary Arterial Hypertension | JACC: Basic to Translational Science
![Management of pulmonary hypertension in left heart disease - Alexander Schmeisser, Hagen Schroetter, Ruediger C. Braun-Dulleaus, 2013 Management of pulmonary hypertension in left heart disease - Alexander Schmeisser, Hagen Schroetter, Ruediger C. Braun-Dulleaus, 2013](https://journals.sagepub.com/cms/10.1177/1753944713477518/asset/images/large/10.1177_1753944713477518-fig1.jpeg)
Management of pulmonary hypertension in left heart disease - Alexander Schmeisser, Hagen Schroetter, Ruediger C. Braun-Dulleaus, 2013
![Certain beta blockers (e.g., bisoprolol) may be reevaluated in hypertension guidelines for patients with left ventricular hypertrophy to diminish the ventricular arrhythmic risk | Journal of Human Hypertension Certain beta blockers (e.g., bisoprolol) may be reevaluated in hypertension guidelines for patients with left ventricular hypertrophy to diminish the ventricular arrhythmic risk | Journal of Human Hypertension](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41371-021-00505-8/MediaObjects/41371_2021_505_Fig1_HTML.png)